On June 8, 2018 the Bill And Melinda Gates Foundations launched a subsidiary, non-profit company, a “biotech-within-a-charity” with an initial $273 million 4-year grant injection. It is called the Bill & Melinda Gates Medical Research Institute (Gates MRI) and is headquartered in Cambridge, Massachusetts. [1, 2]
The start up company is said to “focus on developing interventions to fight persistent epidemics, such as malaria, tuberculosis, and enteric and diarrheal diseases”.
“Gates MRI hopes to apply new understanding of the human immune system learned from cancer research to prevent infectious disease, and plans to take drugs, vaccines and other assets from preclinical stages all the way through clinical trials to regulatory approval” [3]